Argenx
ARGX
#560
Rank
C$48.06 B
Marketcap
$788.11
Share price
-6.02%
Change (1 day)
46.24%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): C$0.12 Billion

According to Argenx 's latest financial reports the company's current earnings are C$2.19 Billion. , an increase over its 2023 earnings that were of -C$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 C$0.12 B-127.97%
2023 -C$0.44 Billion-58.25%
2022 -C$1.04 Billion
2019 -C$0.29 Billion124.95%
2018 -C$0.13 Billion132.04%
2017 -C$54.21 Million54.86%
2016 -C$35.01 Million33%
2015 -C$26.32 Million13.63%
2014 -C$23.17 Million46.25%
2013 -C$15.84 Million